Chitosan 用于 High Cholesterol (Hyperlipidemia)
CCochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.
结论
Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.
Key Statistics
14
研究数量
1100
受试者
Positive
等级
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- fatbinding:
- 1,500-3,000 mg/day before meals
- cholesterolsupport:
- 1,000-3,000 mg/day
上限: Not formally established; GI side effects at higher doses
最佳服用时间: 15-30 minutes before meals containing dietary fat
Safety & Side Effects
已报告的副作用
- ⚠ Constipation
- ⚠ Gas and bloating
- ⚠ Nausea
- ⚠ Allergic reactions in those with shellfish allergy (contraindicated)
已知相互作用
- ● Fat-soluble vitamins (A, D, E, K — may reduce absorption)
- ● Oral medications (may bind and reduce absorption — separate by 2 hours)
- ● Warfarin (may reduce vitamin K absorption, affecting INR)
可耐受最高摄入量: Not formally established; GI side effects at higher doses
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Chitosan help with High Cholesterol (Hyperlipidemia)?
How much Chitosan should I take for High Cholesterol (Hyperlipidemia)?
Are there side effects of Chitosan?
How strong is the evidence for Chitosan and High Cholesterol (Hyperlipidemia)?
Related Evidence
其他成分用于 High Cholesterol (Hyperlipidemia)
Chitosan 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。